Mikhail S. Shchepinov

Mikhail S. Shchepinov, Ph.D. is a founder of Retrotope and also serves as the company’s chief scientific officer. In this role, he oversees the company’s efforts to employ stable isotopes to reinforce biomolecules against disease of oxidative stress and aging. Prior to Retrotope, Dr. Shchepinov held positions at biotechnology companies in both the U.S. and Europe, making key contributions to their development of novel chemical tools for genomics and proteomics. These included San Diego-based Sequenom and Tridend Technologies in Oxford, UK.

Dr. Shchepinov completed his postdoc studies at Oxford University with a focus on bioorganic, combinatorial and surface chemistries. He also completed his Ph.D. at Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry in Moscow (1994) and his master’s degree from Mendeleev Institute of Chemical Technology in Moscow, USSR.